FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Collagen Matrix’s Moldable Spinal Bone Graft Cleared by FDA

April 18, 2019
A A

Collagen Matrix received 510(k) clearance from the FDA for its OssiMend product, a bioactive moldable bone graft matrix used in the spine.

The spinal bone graft, which is made of highly purified collagen, bioactive glass and anorganic bone mineral, can be molded into putty to allow for bony ingrowth in irregular defect sites.

The product is slowly resorbed during a patient’s natural healing process to be replaced by new bone tissue. The matrix is available in multiple sizes for complex spine fusion surgeries.

View today's stories